Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1995
10/10/1995US5457181 Preparation of a high-purity human factor IX concentrate and other plasmatic proteins and their therapeutic use
10/10/1995US5457180 Methods for producing linear thiopeptides using an amino acid ortho amino thioanilide compound
10/10/1995US5457178 Protein isolated from Filistata spider venom causing flaccid paralysis when injected into Lepidoptera larvae
10/10/1995US5457114 Antithrombin; antithrombotic, enzyme resistance, tolerability
10/10/1995US5457093 Gel formulations containing growth factors
10/10/1995US5457092 Hormone is modified by deletion of N-terminus and C-terminus of amino acid residues of +28 to +34; administering for mitogenesis and bone-specific effect
10/10/1995US5457090 A serine proteolytic enzyme inhibitor
10/10/1995US5457089 Muteins of human erythropoietin, the preparation thereof and the use thereof
10/10/1995US5457066 Treating with trypsin and carboxypeptidase b in aqueous medium containing nickel ions in specified concentrations and weight ratios
10/10/1995US5457049 Tumor suppressor protein pRb2, related gene products, and DNA encoding therefor
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5457042 Sod polypeptide analogs
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995US5457034 Vectors for expression of NGF in eukaryotic cells
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995US5456910 Antibiotic stalobacins
10/10/1995US5456909 Used in therapy and diagnosis of inflammatory and immune disorders
10/05/1995WO1995026409A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF)
10/05/1995WO1995026408A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf)
10/05/1995WO1995026404A1 Cell-surface polypeptide gene
10/05/1995WO1995026403A1 Antibodies against e-selectin
10/05/1995WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use
10/05/1995WO1995026363A1 Neurotrophin-6: a new member of the neurotrophin family
10/05/1995WO1995026362A1 Peptides for diagnostics and therapeutics
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026204A1 Immune stimulation by phosphorothioate oligonucleotide analogs
10/05/1995WO1995026203A1 Wound healing
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026201A1 Brevican, a glial cell proteoglycan
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995026195A1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage
10/05/1995WO1995026190A1 Novel anti-hiv drug
10/05/1995WO1995026136A1 Parasite enzyme inhibitors and substrate analogs
10/05/1995WO1995024650A3 Methods of diagnosing and treating preeclampsia
10/05/1995WO1995021611A3 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
10/05/1995WO1995018618A3 Enteral formula with ribo-nucleotides
10/05/1995DE4411402A1 DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen DNA expression vectors for use in gene therapy of vascular diseases
10/05/1995DE4411025A1 New lipopeptide A1437 derivs. with modified acyl gp.
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186455A1 Antibodies against e-selectin
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995CA2184755A1 Recombinant adenoviruses coding for basic fibroblast growth factors (bfgf)
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/05/1995CA2163743A1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
10/04/1995EP0675135A2 Protein PHBP-70, having heparin binding and fibroblast proliferating properties
10/04/1995EP0675112A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/04/1995EP0674906A2 Thrombolytic agent containing plasmin and a plasminogen activator
10/04/1995EP0674716A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
10/04/1995EP0674714A1 Recombinant canine gastric lipase and pharmaceutical compositions
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0674661A1 Assay and treatment for demyelinating diseases such as multiple sclerosis
10/04/1995EP0674660A1 Multifunctional neurotrophic factors
10/04/1995EP0674659A1 Peptides and vaccines derived from nematode tubulin
10/04/1995EP0674658A1 A novel protein tyrosine kinase
10/04/1995EP0674657A1 Gp41 mutants and their use as hiv therapeutics
10/04/1995EP0674655A1 Acyclic peptide analogs of the atrial natriuretic peptide, process for producing the same and their use
10/04/1995EP0674654A1 Acyclic, sulphureous peptides as analogs of the atrial natriuretic peptide
10/04/1995EP0674653A1 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same
10/04/1995EP0674652A1 Dolostatin analog
10/04/1995EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/1995EP0674531A1 Process for preparing a virus-safe biological composition
10/04/1995EP0674528A1 Cyclodextrin and polymer based drug delivery system
10/04/1995EP0674526A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
10/04/1995EP0674525A1 Aqueous pharmaceutical preparations of g-csf with a long shelf life
10/04/1995EP0674524A1 Stable lyophilized pharmaceutical preparations g-csf
10/04/1995EP0674506A1 Controlled release growth hormone containing microspheres
10/04/1995EP0271577B1 Immunomodulating compositions and their use
10/04/1995CN1109508A Full DNA sequence of recombinative glucokinase
10/04/1995CN1109507A Preparation for high efficiency anti-tumor gama-type interferon mutant and use
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/04/1995CN1109468A Sulfonamido heterocyclic thrombin inhibitors
10/04/1995CN1109364A Insulin formulation
10/03/1995US5455338 Anticoagulants; protease inhibitors; thrombosis; surgery
10/03/1995US5455337 Treatment of asthma, helminth infections
10/03/1995US5455330 Isolated pure protein having specified amino acid sequence
10/03/1995US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/03/1995US5455279 Regimen method of mediating neuronal damage using nitroglycerine
10/03/1995US5455242 Analgesics, hypotensive or cardiotonic agents, diuretics, antidepressants or suppressors of vascular response after angioplasty
10/03/1995US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
10/03/1995US5455230 Delta opioid receptor antagonists and their use as analgesic agents
10/03/1995US5455229 A tripeptide based on a alanine, proline and arginine derivative; protease inhibitors; myocardial infarctions
10/03/1995US5455228 Peptidase resistant thrombin receptor peptide ligand
10/03/1995US5455227 Biologically active lipoprotein and its use
10/03/1995US5455226 Administering epidermal growth factor to stimulate repair of respiratory epithelial wounds
10/03/1995US5455181 Anticoagulant
10/03/1995US5455179 Quantitative analysis using polypeptide
10/03/1995US5455168 α-glycosyl trehalose-forming enzyme
10/03/1995US5455165 Nucleic acids encoding polypeptides useful as cell surface adhesion molecules; therapy, diagnosis
10/03/1995US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995US5455030 Immunotheraphy using single chain polypeptide binding molecules
10/03/1995US5455029 Therapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogs
10/01/1995CA2146059A1 Imidazole-containing inhibitors of farnesyl protein transferase
1 ... 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 ... 3163